-

AHF Advocates to Keep Hammering Gilead CEO over Drug Profiteering

Protest Friday, June 16th will target drug company CEO at company’s Foster City HQ

SAN FRANCISCO--(BUSINESS WIRE)--On Friday, June 16th, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF) will host a protest targeting HIV and Hepatitis C drug giant Gilead Sciences over the Bay Area company’s drug pricing and policies. The protest will take place in front of Gilead’s headquarters in Foster City, CA. The action is part of a yearlong aggressive advocacy campaign by AHF hammering Gilead and Daniel O’Day, its multimillionaire CEO, over his and the company’s drug profiteering.

WHAT:

 

Protest at Gilead Sciences HQ

 

 

 

WHEN:

 

Friday, June 16 - 12:00 p.m.

 

 

 

WHERE:

 

Gilead Sciences, Inc. Headquarters

 

 

333 Lakeside Dr., Foster City, CA 94404

 

 

 

WHO:

 

20 health advocates & mobilizers

AHF Onsite Foster City Media Contact: Jesse Brooks, +1.510.575.8245 cell jesse.brooks@ahf.org

According to CEO World Magazine, Daniel O’Day, Chairman and CEO of Gilead Sciences, was the 4th highest paid CEO in the healthcare industry in 2022 with total compensation of $21,621,253.

Advocates are protesting Gilead’s tone-deaf greed, particularly illegal restrictions the company placed early last year on access to 340B drug pricing for its branded hepatitis C treatments for certain pharmacies. Gilead now is one of more than 15 major drug companies that illegally have placed such restrictions on drugs.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth, follow us @aidshealthcare or subscribe to our AHF podcast “AHFter Hours.”

Contacts

Ged Kenslea, AHF Senior Communications Director
323.791.5526
ged.kenslea@ahf.org

AIDS Healthcare Foundation


Release Summary
Advocates to Keep Hammering Gilead CEO over Drug Profiteering
Release Versions

Contacts

Ged Kenslea, AHF Senior Communications Director
323.791.5526
ged.kenslea@ahf.org

More News From AIDS Healthcare Foundation

AHF Hails Introduction of Protect 340B Act of 2026

WASHINGTON--(BUSINESS WIRE)--AHF Hails Introduction of Protect 340B Act of 2026...

AHF Urges African Nations to Take Charge of Medicines Regulation

KIGALI, Rwanda--(BUSINESS WIRE)--With more than 20 African Union Member States yet to ratify the African Medicines Agency (AMA) Treaty, AIDS Healthcare Foundation (AHF) calls on African governments to accelerate ratification and regulatory harmonisation to expand access to affordable medicines and unlock Africa’s pharmaceutical manufacturing potential.The call comes as AMA convenes its inaugural week in Kigali, Rwanda, from 25–30 October 2026, against a backdrop of continued dependence on import...

Treatment = Life: AHF Reaches 2 Million Patients in Care in Africa

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) has surpassed 2 million patients in care across 15 African countries, marking a historic achievement 25 years after beginning its first programs outside the United States in South Africa and Uganda. With programs in four additional countries expected to launch in 2027, AHF is recognizing the communities and partnerships behind this progress while calling for urgent action to close persistent gaps in the HIV response. AHF’s work...
Back to Newsroom